Ken Griffin’s 2ndVote Life Neutral Plus ETF LYFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,262
Closed -$343K 15562
2023
Q2
$343K Sell
10,262
-2,420
-19% -$76.5K ﹤0.01% 8747
2023
Q1
$399K Hold
12,682
﹤0.01% 8778
2022
Q4
$368K Sell
12,682
-6,534
-34% -$195K ﹤0.01% 8887
2022
Q3
$526K Buy
19,216
+7,501
+64% +$220K ﹤0.01% 8348
2022
Q2
$326K Buy
+11,715
New +$352K ﹤0.01% 9627
2022
Q1
Sell
-20,860
Closed -$704K 14976
2021
Q4
$704K Buy
20,860
+3,015
+17% +$97.8K ﹤0.01% 8833
2021
Q3
$545K Sell
17,845
-15
-0.1% -$467 ﹤0.01% 9652
2021
Q2
$543K Buy
+17,860
New +$534K ﹤0.01% 9894

Other funds holding LYFE

Ken Griffin's LYFE Position: Q3 2023 in Review

Ken Griffin sold out of 2ndVote Life Neutral Plus ETF (LYFE) in Q3 2023, closing a stake of 10,262 shares — an estimated $343K sold.

Ken Griffin first reported a position in LYFE in Q2 2021 and held it in 8 quarters. The position peaked at $704K in Q4 2021. 1 fund tracked by Wall St. Rank holds LYFE as of Q3 2023.

  • Ken Griffin reported no remaining 2ndVote Life Neutral Plus ETF position as of Q3 2023 after selling out during the quarter.
  • Ken Griffin sold 10,262 2ndVote Life Neutral Plus ETF shares in Q3 2023, an estimated $343K.
  • Ken Griffin first reported a position in 2ndVote Life Neutral Plus ETF in Q2 2021 and held it in 8 quarters.
  • Ken Griffin's 2ndVote Life Neutral Plus ETF position peaked at $704K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held 2ndVote Life Neutral Plus ETF as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.